Glucocorticoids in Autoimmune Bullous Diseases: Are Neutrophils the Key Cellular Target?
Overview
Authors
Affiliations
The newly observed nongenomic effects of glucocorticoids on signaling pathways operating in neutrophils in vitro will stimulate further investigations on pathogenic mechanisms and drug actions in bullous skin diseases.
The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases.
Zeng L, Xiang W, Xiao W, Wu Y, Sun L MedComm (2020). 2025; 6(3):e70101.
PMID: 40060194 PMC: 11885892. DOI: 10.1002/mco2.70101.
Wang C, Bischof E, Xu J, Guo Q, Zheng G, Ge W Front Cardiovasc Med. 2022; 9:894004.
PMID: 35872886 PMC: 9301050. DOI: 10.3389/fcvm.2022.894004.
Chonde M, Flickinger K, Sundermann M, Koller A, Salcido D, Dezfulian C Biomed Res Int. 2019; 2019:6539050.
PMID: 31309111 PMC: 6594305. DOI: 10.1155/2019/6539050.
The expanding role of immunopharmacology: IUPHAR Review 16.
Tiligada E, Ishii M, Riccardi C, Spedding M, Simon H, Teixeira M Br J Pharmacol. 2015; 172(17):4217-27.
PMID: 26173913 PMC: 4556463. DOI: 10.1111/bph.13219.
Glucocorticoids as an emerging pharmacologic agent for cardiopulmonary resuscitation.
Varvarousi G, Stefaniotou A, Varvaroussis D, Xanthos T Cardiovasc Drugs Ther. 2014; 28(5):477-88.
PMID: 25163464 PMC: 4163188. DOI: 10.1007/s10557-014-6547-4.